October 04, 2026 05:18 am (IST)
Follow us:
Pharmaceuticals dept visits USP India facility in Hyderabad
Hyderabad / Kolkata, Feb 5 (IBNS): Sudhansh Pant, Joint Secretary, Department of Pharmaceuticals (DoP), visited the US Pharmacopeia's (USP) state-of-the-art India facility in Hyderabad.
He toured the facility and met with senior level scientists. The purpose of this visit was to better understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality of medicines and bring to India international standards in drug manufacture.
India’s continued export growth in pharmaceuticals requires that every drug exported meets with the highest quality and safety requirements. USP is uniquely positioned to provide guidelines in this area.
USP develops the reference standards to ensure the quality of Active Pharmaceutical Ingredients (APIs) and is supportive of government initiatives to strengthen and revive the domestic manufacturing of intermediaries and APIs.
The Joint Secretary’s discussion with USP India touched upon various aspects of ensuring the quality of medicines in India and how USP standards could help Indian manufacturers to import their products both to the US and to other countries.
Pant also enquired about the verification program and process and showed interest in the education and training programs conducted by USP. He was very impressed by the state-of-the-art facility and appreciated the quality and safety aspects maintained in the facility.
KV Surendranath, Senior Vice President- International Sites Operations said, “We welcome this opportunity to showcase our technical expertise to the Department of Pharmaceuticals. We see ourselves as partners in India’s efforts to produce safe and high quality medicines that meet all global standards. We hope to continue with future engagements with the DoP on various aspects related to quality of medicines and to address issues of critical importance to patient safety.”
Sudhansh Pant commented that he was very impressed and that the visit was quite enlightening and informative. He noted the commendable work being done at the facility in the field of standards, testing and research and the various collaborations in the interest of the Indian pharmaceutical industry. Mr. Pant hopes that other governments and private institutions will benefit from the presence of USP’s world class facility in Hyderabad.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Life expectancy is rising again after COVID-19 shock: WHO reveals global health comeback
Sat, Oct 03 2026
From physiotherapy to AI, robotics: MRCCon 2026 highlights how medical rehabilitation has transformed in 27 years
Fri, Oct 02 2026
Study finds chewing tobacco linked to 2.5 lakh deaths worldwide; India among worst-affected countries
Fri, Oct 02 2026
Kolkata's Desun Hospital's Cardio Care Walkathon daws 200 participants on World Heart Day
Fri, Oct 02 2026
Insomnia is more than just sleepless nights: Study finds higher stroke, dementia risk
Tue, Sep 29 2026
Manipal Hospital Dhakuria hosts ‘Heart of Innovation Cardiac Summit’ ahead of World Heart Day
Mon, Sep 28 2026
Eating with your partner could lower blood sugar spikes, study finds
Sun, Sep 27 2026
The 10-hour weight-loss rule: What Johns Hopkins researchers discovered will leave obese, prediabetic patients happy?
Sun, Sep 27 2026
Loneliness could cost you nearly 6 healthy years, major study finds
Sun, Sep 27 2026